⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARVN News
Arvinas, Inc
New nanoparticle technology offers hope for hard-to-treat diseases
globenewswire.com
ARVN
PFE
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
businesswire.com
QTRX
ILMN
EXAS
DGX
PFE
ARVN
Silver Dollar City Honors America's 250th with Free Season Passports for Active Military, season-long celebrations
prnewswire.com
ARVN
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
globenewswire.com
ARVN
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
ARVN
Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)
globenewswire.com
ARVN
PFE
Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
ARVN
Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting
globenewswire.com
ARVN
Arvinas to Participate in Upcoming Investor Conferences
globenewswire.com
ARVN
Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025
globenewswire.com
ARVN